ARAY Stock - Accuray Inc.

ARAY Stock Chart

ARAY Profile

Accuray Incorporated specializes in the design, development, manufacturing, and distribution of advanced radiosurgery and radiation therapy systems used globally for treating tumors. Operating across the Americas, Europe, Asia Pacific, and other regions, the company offers innovative solutions such as the CyberKnife System. This robotic stereotactic radiosurgery and stereotactic body radiation therapy platform is pivotal for treating primary and metastatic tumors located beyond the brain, including those affecting critical areas like the spine, breast, kidney, liver, lung, pancreas, and prostate.

Accuray also features the TomoTherapy System, including the Radixact System, which integrates radiation treatment planning, delivery, and data management. This technology empowers clinicians to administer highly precise treatments, catering to approximately 50 patients daily. Beyond product offerings, the company provides comprehensive post-contract customer support, installation services, training, and professional assistance to enhance treatment efficacy and patient care.

Founded in 1990 and headquartered in Sunnyvale, California, Accuray Incorporated serves a diverse customer base that includes hospitals, independent treatment centers, and healthcare facilities worldwide. Through its direct sales force, distributors, and partnerships with group purchasing organizations, Accuray ensures its cutting-edge medical solutions reach healthcare providers efficiently across various global markets.

ARAY Revenue Chart

ARAY Earnings

Analyst Ratings